Lpl Financial LLC Annovis Bio, Inc. Transaction History

Lpl Financial LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.55 - $19.62 $58,763 - $207,736	10,588 New	10,588 $197,000
Q3 2021 Nov 15, 2021	SELL	$30.95 - $120.97 $119,714 - $467,911	-3,868 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$21.55 - $96.1 $83,355 - $371,714	3,868 New	3,868 $331,000

1.2M

779K

1.77M

Ticker ANVS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,163,920
Market Cap $45.4M
Description
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.